Why pharma has been slow to engage its customers, and what we can do about it.
Sales and Marketing: IMS projects narrowing use gap, slowing med spend growth over next five years
Analysts, Autoimmune Disorders, Behavioral Changes, December 2015, Drug Spending, Electronic Health Records, EMR, Forecasts, Generics, Health, Heart Disease, Hepatitis, Hepatitis C, Hepatitis C Infections, Innovation, Issue Archives, Mobile Health, Oncology, Population, Prescriptions, R&D, Rare Diseases, Studies, Tablets, Technology, Therapeutics, WearablesMore than half of the world’s population will live in countries where medicine use will exceed one dose per person per day by 2020, up from 31 percent in 2005, as the “medicine use gap” between developed and pharmerging markets narrows, according to research by the IMS Institute for Healthcare Informatics.